Published on
October 9, 2024
- 14:00 GMT
USPTO Grants AOBiome Therapeutics Composition of Matter Patent for its Clinical Candidate B244
B244 has demonstrated clinical efficacy on therapeutic indications including: Atopic Dermatitis (Eczema) and Pruritus (Itch), and Acne Vulgaris (Acne) CAMBRIDGE, MA, UNITED STATES, October 9, 2024 /EINPresswire.com/ -- USPTO Grants AOBiome Therapeutics …
Distribution channels:
Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry
...
